Susquehanna International Group
EPIX

Susquehanna International Group’s ESSA Pharma EPIX Stock Holding History

Susquehanna International Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-384,200
Closed -$73K – 12655
2025
Q3 		$73K Buy
384,200
+8,100
+2% +$9.71K ﹤0.01% 11727
2025
Q2 		$639K Buy
+376,100
New +$635K ﹤0.01% 8599
2024
Q4 		– Sell
-15,100
Closed -$91.5K – 12442
2024
Q3 		$91.5K Sell
15,100
-18,000
-54% -$98.9K ﹤0.01% 11101
2024
Q2 		$174K Sell
33,100
-14,000
-30% -$89K ﹤0.01% 10538
2024
Q1 		$400K Buy
47,100
+900
+2% +$7.86K ﹤0.01% 9034
2023
Q4 		$305K Buy
+46,200
New +$228K ﹤0.01% 9804
2023
Q3 		– Sell
-11,600
Closed -$31.3K – 12238
2023
Q2 		$31.3K Sell
11,600
-60,500
-84% -$177K ﹤0.01% 11503
2023
Q1 		$214K Buy
72,100
+55,000
+322% +$162K ﹤0.01% 10454
2022
Q4 		$43.1K Buy
+17,100
New +$49.1K ﹤0.01% 11468

Susquehanna International Group's EPIX Position: Q1 2025 in Review

Susquehanna International Group sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 17,704 shares — an estimated $31.7K sold.

Susquehanna International Group first reported a position in EPIX in Q4 2017 and held it in 6 quarters. The position peaked at $296K in Q3 2023. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

  • Susquehanna International Group reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 17,704 ESSA Pharma shares in Q1 2025, an estimated $31.7K.
  • Susquehanna International Group first reported a position in ESSA Pharma in Q4 2017 and held it in 6 quarters.
  • Susquehanna International Group's ESSA Pharma position peaked at $296K in Q3 2023.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.